Eagle Pharmaceuticals
EGRX
#10347
Rank
โ‚ฌ7.79 M
Marketcap
0,60ย โ‚ฌ
Share price
0.00%
Change (1 day)
-25.27%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: โ‚ฌ7.79 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of โ‚ฌ7.79 Million. This makes Eagle Pharmaceuticals the world's 10347th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ7.79 M13.75%
2024โ‚ฌ6.84 M-88.85%
2023โ‚ฌ61.44 M-82.68%
2022โ‚ฌ0.35 B-38.92%
2021โ‚ฌ0.58 B17.69%
2020โ‚ฌ0.49 B-32.51%
2019โ‚ฌ0.73 B49.18%
2018โ‚ฌ0.49 B-26.24%
2017โ‚ฌ0.66 B-43.09%
2016โ‚ฌ1.16 B-7.94%
2015โ‚ฌ1.26 B608.84%
2014โ‚ฌ0.17 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
โ‚ฌ7.79 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ417.86 B 5,363,386.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ83.93 B 1,077,191.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚ฌ217.80 B 2,795,559.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.04 B 359,866.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
โ‚ฌ152.57 B 1,958,274.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ777.90 B 9,984,723.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ91.18 B 1,170,304.01%๐Ÿ‡บ๐Ÿ‡ธ USA